secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2026-01-15T23:59:59+00:00
Accession:  0001104659-26-004146
Event type: litigation
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

NWBO settles 2020 option litigation; insurer pays $2.25M, 17% options cancelled
-------------------------------------------------------------------------------

- Settlement agreement entered Dec 12, 2025 for litigation over 2020 option awards.
- Insurance carriers to pay $2.25 million to the company.
- 17% of challenged 2020 options will be cancelled.
- Plaintiff may seek up to $3.5M in attorney fees, paid separately by insurers.
- Court approval hearing set for 1:30 pm ET on March 16, 2026 in Delaware.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465926004146/0001104659-26-004146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465926004146/tm263317d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-004146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer